Catalyst Wire Dossier Catalyst Wire Dossier

Eveotox

recombinant botulinum toxin type A · JHM BioPharma (Tonghua) Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Eveotox, covering 2025-09-02 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity . [Phase 3]

See pricing